Latest Proof Of Concept News

PYC Therapeutics has made significant progress across its four RNA therapeutic programs, including dose escalation approvals in its Polycystic Kidney Disease trial and orphan drug designation for its Retinitis Pigmentosa candidate, supported by a robust cash position of $669 million.

DXN Limited has landed a $1.2 million contract for a key Pacific submarine cable project while advancing its maiden AI HPC modular data centre deal and expanding manufacturing in Southeast Asia.

Wide Open Agriculture (ASX: WOA) is executing a major strategic pivot by closing its German production site and transitioning to a capital-light contract manufacturing model to improve economics and scale lupin protein production.

Way2VAT Ltd lifted its Q2 FY26 revenue by 30%, launching the Way2Invoice e-invoicing platform amid growing global VAT compliance demands. The company also expanded its debt facility to support growth and pursue M&A opportunities.

Resonance Health (ASX:RHT) closed FY26 with a net operating cash inflow of $2.9 million and completed recruitment for a $13.8 million clinical trial, underpinning a robust contract pipeline and growing net cash position.

Polymetals Resources continues to confirm substantial high-grade silver-lead-zinc mineralisation at the Endeavor Mine's upper Main Lode, progressing towards a new Mineral Resource estimate.

EV Resources has successfully commissioned the flotation circuit at its Tecomatlán plant, setting the stage for processing bulk ore and producing its first marketable antimony concentrate as it advances toward commercial production.

Pure Resources has achieved a key early milestone with Oak Ridge National Laboratory confirming the recovery of heavy rare earth elements from garnet concentrate at its Garnet Hills Project. While still at proof-of-concept stage, this validates the potential for a new source of critical minerals.

Actinogen Medical’s phase 2 trial of Xanamem in major depressive disorder with cognitive impairment reveals meaningful antidepressant effects, published in the British Journal of Psychiatry. The drug was safe and well-tolerated but did not improve cognition.

Norwood Systems lifted FY26 customer cash receipts to a record A$2.327 million, driven by multiple Tier-1 carrier contracts and successful AI pilot completions in Australia and the UK.

Southern Cross Gold’s first deep drilling beneath Victoria’s historic Redcastle Goldfield has returned multiple high-grade gold and antimony hits, confirming the presence of Costerfield-style mineralization over a significant vertical extent.

G50 Corp's latest metallurgical tests at Golconda confirm low-cost recovery of gallium alongside gold and silver, reinforcing its potential as a strategic domestic supplier of critical minerals.